Search

Your search keyword '"Renton, A. E."' showing total 310 results

Search Constraints

Start Over You searched for: Author "Renton, A. E." Remove constraint Author: "Renton, A. E."
310 results on '"Renton, A. E."'

Search Results

1. Investigation of the genetic aetiology of Lewy body diseases with and without dementia

2. Author Correction: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

3. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

5. The complex genetic architecture of Alzheimer's disease: novel insights and future directions

6. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

7. CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease

8. γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

9. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

10. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

11. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

12. Genome-wide association study and functional validation implicates JADE1 in tauopathy

13. Genome-wide association study and functional validation implicates JADE1 in tauopathy

14. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

15. Discovery and validation of dominantly inherited Alzheimer’s disease mutations in populations from Latin America

16. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

17. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study

18. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

19. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

20. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

21. Ubiquitin‐Proteasome System in Different Staging of Dominantly Inherited Alzheimer’s Disease

22. Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network

26. The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease

27. A Genome-Wide Association Study of Myasthenia Gravis

28. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases

29. Genome‐Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the CETP Gene

30. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

31. Gene expression and genetic analyses in Parkinson's disease with and without dementia

32. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

33. Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network.

34. Validation of newly derived polygenic risk scores for dementia in a prospective study of older individuals.

36. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

40. Discovery and validation of dominantly Inherited Alzheimer’s Disease mutations in populations from Latin America.

42. A Social and Environmental History of the Horse in Spain and Spanish America, 1492-1600

44. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

45. Additional file 5 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

46. Additional file 2 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

47. Additional file 10 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

48. Additional file 3 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

49. Additional file 7 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

50. Additional file 6 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Catalog

Books, media, physical & digital resources